Fri, Aug 22, 2014, 6:34 AM EDT - U.S. Markets open in 2 hrs 56 mins


% | $
Quotes you view appear here for quick access.

Pharmacyclics Inc. Message Board

  • jgmtruth jgmtruth Apr 17, 2013 9:30 AM Flag

    Soon folks.Strong first quarter for J&J thanks to new products

    Healthy pipeline

    Commenting on the results, Ana Nicholls, healthcare analyst at The Economist Intelligence Unit, said that J&J has put its patent expiries behind it, and is benefiting from strong sales of new products such as Xarelto. She also likes the look of its newer drugs such as the "ground-breaking" diabetes drugs Invokana (canagliflozin), which was approved in the USA at the end of March, as well as two therapies lined up for approval - the hepatitis C treatment simeprevir and the leukaemia drug ibrutinib.

    Sentiment: Strong Buy

118.54-1.86(-1.54%)Aug 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.